Adiponectin inhibits activation and injury of lung endothelium

脂联素抑制肺内皮细胞的活化和损伤

基本信息

  • 批准号:
    8852162
  • 负责人:
  • 金额:
    $ 38.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-01 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This grant studies the molecular interaction between lung and adipose tissue mediated by the adipocyte-derived hormone adiponectin. Adiponectin has been shown to act in murine lung to tonically inhibit endothelial cell activation and to limit injury originating from endothelial cell damage (e.g. hyperoxia). This proposal will utilize a broad range of genetic tools (e.g. adiponectin and adiponectin receptor deficient mice) and reagents (e.g. recombinant adiponectin protein, adenoviral vectors) to perform the first comprehensive examination of adiponectin's role in lung vascular homeostasis. Studies in Aim 1 will identify the oligomeric fractions and key structural domains mediating adiponectin's effects on lung endothelium and will elucidate the down-stream signaling pathways of adiponectin on lung endothelium. Studies in Aim 2 are designed to test the hypothesis that adiponectin mitigates lung injury to hyperoxia by activating anti- inflammatory and cyto-protective processes on lung endothelium. Finally, studies in Aim 3 will utilize in vitro and in vivo tools to identify the important adiponectin receptor mediating adiponectin's effects in lung. Taken together, studies in this grant will identify the molecular mechanisms by which APN regulates lung vascular processes in the hope of identifying new avenues of research in lung vascular biology and laying the foundation for the rational design of future clinical investigations examining APN in human lung disease.
描述(申请人提供):这项资助研究脂肪细胞衍生荷尔蒙脂联素介导的肺和脂肪组织之间的分子相互作用。脂联素已被证明在小鼠肺中作用于张力抑制内皮细胞激活和限制由内皮细胞损伤(如高氧)引起的损伤。这项建议将利用广泛的遗传工具(例如脂联素和脂联素受体缺陷小鼠)和试剂(例如重组脂联素蛋白、腺病毒载体)来首次全面检查脂联素在肺血管稳态中的作用。目标1的研究将确定脂联素对肺内皮细胞影响的低聚组分和关键结构域,并将阐明脂联素对肺内皮细胞的下游信号通路。AIM 2中的研究旨在验证脂联素通过激活肺内皮细胞上的抗炎和细胞保护过程来减轻高氧所致肺损伤的假设。最后,AIM 3的研究将利用体外和体内工具来确定重要的脂联素受体介导脂联素在肺中的作用。综上所述,这项拨款的研究将确定APN调节肺血管过程的分子机制,希望找到肺血管生物学研究的新途径,并为未来合理设计APN在人类肺部疾病中的临床研究奠定基础。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury.
在急性肺损伤的小鼠模型中,细胞外 ATP 介导中性粒细胞募集到肺部的后期。
Acute respiratory distress syndrome: epidemiology and management approaches.
  • DOI:
    10.2147/clep.s28800
  • 发表时间:
    2012-01-01
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Walkey, Allan J;Summer, Ross;Alkana, Philip
  • 通讯作者:
    Alkana, Philip
Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?
  • DOI:
    10.4103/2045-8932.93542
  • 发表时间:
    2011-10
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Summer R;Walsh K;Medoff BD
  • 通讯作者:
    Medoff BD
Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
  • DOI:
    10.1016/j.lfs.2015.01.005
  • 发表时间:
    2015-03-01
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Rincón J;Correia D;Arcaya JL;Finol E;Fernández A;Pérez M;Yaguas K;Talavera E;Chávez M;Summer R;Romero F
  • 通讯作者:
    Romero F
Cavin1; a regulator of lung function and macrophage phenotype.
  • DOI:
    10.1371/journal.pone.0062045
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Govender P;Romero F;Shah D;Paez J;Ding SY;Liu L;Gower A;Baez E;Aly SS;Pilch P;Summer R
  • 通讯作者:
    Summer R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ross S Summer其他文献

Ross S Summer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ross S Summer', 18)}}的其他基金

Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
靶向乳胶蛋白信号传导治疗炎症性肺损伤中的内皮屏障功能障碍
  • 批准号:
    10661225
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
靶向乳胶蛋白信号传导治疗炎症性肺损伤中的内皮屏障功能障碍
  • 批准号:
    10676165
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
靶向乳胶蛋白信号传导治疗炎症性肺损伤中的内皮屏障功能障碍
  • 批准号:
    10677334
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
靶向乳胶蛋白信号传导治疗炎症性肺损伤中的内皮屏障功能障碍
  • 批准号:
    10457247
  • 财政年份:
    2021
  • 资助金额:
    $ 38.17万
  • 项目类别:
Soft LXR Agonists for Idiopathic Pulmonary Fibrosis
软 LXR 激动剂治疗特发性肺纤维化
  • 批准号:
    10079758
  • 财政年份:
    2020
  • 资助金额:
    $ 38.17万
  • 项目类别:
Metabolic control of DNA repair in pulmonary fibrosis
肺纤维化中 DNA 修复的代谢控制
  • 批准号:
    9238175
  • 财政年份:
    2017
  • 资助金额:
    $ 38.17万
  • 项目类别:
Metabolic control of DNA repair in pulmonary fibrosis
肺纤维化中 DNA 修复的代谢控制
  • 批准号:
    9405624
  • 财政年份:
    2017
  • 资助金额:
    $ 38.17万
  • 项目类别:
Adiponectin inhibits activation and injury of lung endothelium
脂联素抑制肺内皮细胞的活化和损伤
  • 批准号:
    8303403
  • 财政年份:
    2011
  • 资助金额:
    $ 38.17万
  • 项目类别:
Adiponectin inhibits activation and injury of lung endothelium
脂联素抑制肺内皮细胞的活化和损伤
  • 批准号:
    8186653
  • 财政年份:
    2011
  • 资助金额:
    $ 38.17万
  • 项目类别:
Adiponectin inhibits activation and injury of lung endothelium
脂联素抑制肺内皮细胞的活化和损伤
  • 批准号:
    8687725
  • 财政年份:
    2011
  • 资助金额:
    $ 38.17万
  • 项目类别:

相似海外基金

Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
  • 批准号:
    19K09482
  • 财政年份:
    2019
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
  • 批准号:
    2273599
  • 财政年份:
    2019
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
  • 批准号:
    18K14964
  • 财政年份:
    2018
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
  • 批准号:
    16K18873
  • 财政年份:
    2016
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
  • 批准号:
    9193681
  • 财政年份:
    2016
  • 资助金额:
    $ 38.17万
  • 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
  • 批准号:
    15K18939
  • 财政年份:
    2015
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
  • 批准号:
    26450450
  • 财政年份:
    2014
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
  • 批准号:
    26893253
  • 财政年份:
    2014
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
  • 批准号:
    26462183
  • 财政年份:
    2014
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
  • 批准号:
    24701021
  • 财政年份:
    2012
  • 资助金额:
    $ 38.17万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了